David Wofsy, MD
Enriched profileProfessor of Medicine and Microbiology/Immunology; George A. Zimmermann Distinguished Professor; Associate Dean for Admissions, UCSF School of Medicine · University of California, San Francisco (UCSF)
David Wofsy is Professor of Medicine and Microbiology/Immunology; George A. Zimmermann Distinguished Professor; Associate Dean for Admissions, UCSF School of Medicine at University of California, San Francisco (UCSF). OpenAlex indexes 208 publications with 16,568 citations (h-index 55); ClinicalTrials.gov lists 7 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
David Wofsy, MD, is Professor of Medicine and Microbiology/Immunology at University of California, San Francisco (UCSF). The public record shows 208 publications with 16,568 citations (h-index 55), centered on Systemic Lupus Erythematosus Research, T-cell and B-cell Immunology, Monoclonal and Polyclonal Antibodies Research. It also documents an investigator role on 7 registered clinical trials, industry payments reported by 8 companies, 7 NIH-funded awards (1985–2019).
- Most recent indexed publication: 2025 · The Journal of experimental medicine
- Top research focus: Systemic Lupus Erythematosus Research
- 7 registered trials on ClinicalTrials.gov
- Open Payments reporting from 8 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 3 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 110.
Clinical & industry
trials, payments and federal fundingPublic positions
sourced statements on record- Member
Arthritis Advisory Committee, U.S. Food and Drug Administration
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucsf.edu ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 7 registered studies on ClinicalTrials.gov. The most recent:
- VIBRANT: VIB4920 for Active Lupus Nephritis
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
- Polyclonal Regulatory T Cells (PolyTregs) for Pemphigus
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
- Autologous Polyclonal Tregs for Lupus
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Industry payments
Updated 27 Aug 2026
8 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Alexion Pharmaceuticals, Inc.Program year20255 payments
- Amgen Inc.Program year20251 payment
- Amgen Inc.Program year20233 payments
NIH funding
Updated 27 Aug 2026
7 NIH research awards on record, funded 1985–2019 per NIH RePORTER. The latest:
- PEARL: Pathway Exploration and Analysis in Renal Lupus
Feinstein Institute for Medical Research
FY2020$1,063,616UH2AR067688 - PEARL: Pathway Exploration and Analysis in Renal Lupus
Feinstein Institute for Medical Research
FY2020$599,210UH2AR067688 - PEARL: Pathway Exploration and Analysis in Renal Lupus
Feinstein Institute for Medical Research
FY2020$469,412UH2AR067688
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- A human-mouse atlas of intrarenal myeloid cells identifies conserved disease-associated macrophages in lupus nephritis.
The Journal of experimental medicine
Article2025 - Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis.
Arthritis & rheumatology (Hoboken, N.J.)
Clinical Trial2021
Most-cited works
by citation count (OpenAlex)- 01
- 02
- 03
- 04
- 05Treatment of Murine Lupus with CTLA4Ig668 citations1994
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/david-wofsy-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/scientific-contributions/David-Wofsy-39765268
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucsf.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →community.the-hospitalist.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →community.the-hospitalist.org ↗
- Rheumatology fellowship
UCSF (under director Bill Seaman)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →community.the-hospitalist.org ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →community.the-hospitalist.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucsf.edu ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucsf.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucsf.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucsf.edu ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →community.the-hospitalist.org ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ucsf.edu ↗
- "Profiles in Rheumatology: Dr. David Wofsy" - biographical feature article
MDedge/The Hospitalist
2018verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →community.the-hospitalist.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ucsf.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Bruce Miller, MD
University of California, San Francisco (UCSF)
Gregory Marcus, MD
University of California, San Francisco (UCSF)
Eric Small, MD
University of California, San Francisco (UCSF)
Adam Boxer, MD
University of California, San Francisco (UCSF)